p53 and little brother p53/47: linking IRES activities with protein functions

被引:0
|
作者
R Grover
M M Candeias
R Fåhraeus
S Das
机构
[1] Indian Institute of Science,Department of Microbiology and Cell Biology
[2] Inserm U716,undefined
[3] Pharmacologie Expérimentale,undefined
[4] Institut Génétique Moléculaire,undefined
[5] Hôpital St Louis and Université Paris 7,undefined
[6] 4Current address: Institute of Bioinformatics and Applied Biotechnology,undefined
[7] Bangalore,undefined
[8] India.,undefined
[9] 5Current address: Department of Clinical Molecular Biology,undefined
[10] Graduate School of Medicine Kyoto University,undefined
[11] Kyoto 606-8507,undefined
[12] Japan.,undefined
来源
Oncogene | 2009年 / 28卷
关键词
p53; p53/47; IRES; translational control;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor p53 represents a paradigm for gene regulation. Its rapid induction in response to DNA damage conditions has been attributed to both increased half-life of p53 protein and also increased translation of p53 mRNA. Recent advances in our understanding of the post-transcriptional regulation of p53 include the discovery of internal ribosome entry sites (IRESs) within the p53 mRNA. These IRES elements regulate the translation of the full length as well as the N-terminally truncated isoform, p53/47. The p53/47 isoform is generated by alternative initiation at an internal AUG codon present within the p53 ORF. The aim of this review is to summarize the role of translational control mechanisms in regulating p53 functions. We discuss here in detail how diverse cellular stress pathways trigger alterations in the cap-dependent and cap-independent translation of p53 mRNA and how changes in the relative expression levels of p53 isoforms result in more differentiated p53 activity.
引用
收藏
页码:2766 / 2772
页数:6
相关论文
共 50 条
  • [11] Generation of p53 suppressor peptide from the fragment of p53 protein
    Mittelman, JM
    Gudkov, AV
    SOMATIC CELL AND MOLECULAR GENETICS, 1999, 25 (03) : 115 - 128
  • [13] The computer search of targets, analysis of p53 gene and p53 protein
    Vishnyakova, AV
    Brit, IS
    Alekseenko, VV
    Odynets, KA
    Belov, YA
    Buchatskiy, LP
    Dyma, PK
    EXPERIMENTAL ONCOLOGY, 2002, 24 (03) : 237 - 238
  • [14] P53 GENE ALTERATIONS AND P53 PROTEIN EXPRESSION IN OVARIAN CANCERS
    KUPRYJANCZYK, J
    BEAUCHAMP, R
    BELL, D
    YANDELL, DW
    THOR, A
    LABORATORY INVESTIGATION, 1993, 68 (01) : A75 - A75
  • [15] Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma
    Liu, Xiao-Fang
    Zhang, Hao
    Zhu, Shi-Guang
    Zhou, Xian-Ting
    Su, Hai-Long
    Xu, Zheng
    Li, Shao-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (29) : 4706 - 4709
  • [17] Mutations in p53, p53 protein overexpression and breast cancer survival
    Rossner, Pavel, Jr.
    Gammon, Marilie D.
    Zhang, Yu-Jing
    Terry, Mary Beth
    Hibshoosh, Hanina
    Memeo, Lorenzo
    Mansukhani, Mahesh
    Long, Chang-Min
    Garbowski, Gail
    Agrawal, Meenakshi
    Kalra, Tara S.
    Gaudet, Mia M.
    Teitelbaum, Susan L.
    Neugut, Alfred I.
    Santella, Regina M.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (9B) : 3847 - 3857
  • [18] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [19] p53 as a sensor of carcinogenic exposures: Mechanisms of p53 protein induction and lessons from p53 gene mutations
    Hainaut, P
    Vahakangas, K
    PATHOLOGIE BIOLOGIE, 1997, 45 (10): : 833 - 844
  • [20] REGULATION OF IRES-MEDIATED TRANSLATION IN P53
    Costa, Ines Fonseca
    Lacerda, Rafaela
    Lopez-Iniesta, Maria
    Romao, Luisa
    Candeias, Marco M.
    MEDICINE, 2021, 100 (04)